Pharmacology · Antidiabetic Drugs (Oral Hypoglycemics, Insulins)

Acarbose, an alpha-glucosidase inhibitor used in type 2 diabetes, exerts its glucose-lowering effect by which mechanism?

  • A Blocking sodium-glucose cotransport in the proximal renal tubule
  • B Inhibiting alpha-glucosidase enzymes at the intestinal brush border, delaying carbohydrate digestion
  • C Activating PPAR-gamma receptors in adipose tissue
  • D Stimulating rapid-phase insulin secretion from beta cells
Correct answer: B. Inhibiting alpha-glucosidase enzymes at the intestinal brush border, delaying carbohydrate digestion

Explanation

Acarbose competitively inhibits alpha-glucosidase enzymes (maltase, sucrase, glucoamylase) in the small intestinal brush border, delaying complex carbohydrate breakdown and glucose absorption. Option A describes SGLT2 inhibitors. Option C describes thiazolidinediones. Option D describes meglitinides or sulfonylureas.

Reference: Katzung Basic and Clinical Pharmacology, 15th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs

See all Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs →